Comparison

DiagnosUs vs Aslami MedCore

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

DiagnosUs

Engage with real medical cases to enhance your diagnostic skills and earn rewards. This educational game is designed for students and professionals to test their knowledge across various specialties and contribute to AI research.

Highlights
  • Analyze diverse medical cases
  • Improve diagnostic skills
  • Earn rewards for participation
  • Contribute to AI research
  • Study for medical exams
  • Regularly updated datasets
Read full description

DiagnosUs is an educational game for medical students, doctors, premed students, other healthcare professionals, and citizen scientists to analyze medical cases, improve their skills, and earn prizes! Participation is open to anyone, regardless of educational background. Players compete against their peers to hone their skills by analyzing cases in our datasets. At the same time, they contribute their knowledge to help advance artificial intelligence research. DiagnosUs is a wonderful supplement for classes, clerkships, and in preparation for exams such as the USMLE® Step 1 & 2 Clinical Knowledge (CK), NBME® exams, MBBS, NCLEX® exams, COMLEX Level 1 & 2, MCAT®, NEET-PG, and many more! The app promotes an engaging, dynamic platform to test anyone’s medical knowledge while simultaneously contributing to the development of crucial machine learning algorithms. Try a wide range of cases in subjects such as radiology, dermatology, USMLE® preparation, MCAT® preparation, NBME® preparation, NCLEX® preparation, ultrasound, neurology, cardiology, ophthalmology, emergency medicine, surgery, internal medicine, pediatrics, orthopedics, family medicine, gastroenterology, pathology, and pulmonology. Utilize the power of DiagnosUs to study interactively! New datasets are added regularly, so players can always keep learning! Learn medicine fast: see a wide range of cases! - Anatomy - Physiology - Auscultation to listen for pulmonary abnormalities - Dermatological images to identify melanoma, basal cell carcinoma, squamous cell carcinoma, psoriasis, dermatitis, and other skin conditions - EEG - EKG / ECG - USMLE® practice questions - MCAT® practice questions - NBME® practice questions - Chest X-rays to look for pneumonia and cancer - Musculoskeletal X-rays - Ultrasound identification problems - Fundus eye images - MRI - Whole Slide Pathology Imagery - Chest CT - Mammograms and much more! The rewards that participants can earn in the app are made possible by our research partners and customers, who are developing artificial intelligence related to image analysis. These research partners and customers subsidize our prizes because our app participants help analyze images from large datasets of our research partners and customers. After participants win rewards, they can tap on the Profile tab and tap on the icon in the top-left corner of the Profile screen. This screen then shows a log of all the participant's rewards, and they can withdraw their rewards to a payment account.

About

Aslami MedCore

This app is a comprehensive study tool for medical students, offering structured learning materials, practice questions, and progress tracking. It supports offline study and is available in multiple languages, preparing users for exams and clinical practice.

Highlights
  • Structured medical systems and topics
  • Thousands of MCQs
  • Daily and weekly quizzes
  • Past paper and clinical case practice
  • Timed exam simulation
  • Progress tracking and analytics
  • Offline study support
Read full description

Aslami MedCore is a complete study companion built for medical students preparing for exams and clinical practice. STUDY SMARTER Access structured medical systems and topics, complete with a built-in reader for books, PDFs, and study notes — organized the way your curriculum is taught. PRACTICE WITH PURPOSE - Thousands of MCQs across every medical system - Daily quiz to build consistency - Past paper practice to prepare for real exams - Clinical case questions to sharpen real-world reasoning - Timed exams that simulate actual test conditions TRACK YOUR PROGRESS See exactly where you stand with detailed analytics on your dashboard — performance by system, topic, and over time. Bookmark tough questions and revisit your mistakes to turn weaknesses into strengths. STUDY YOUR WAY - Flashcards for quick review - Personal notes and to-dos - Weekly exams to stay on track - Leaderboard to see how you compare with peers STUDY OFFLINE Download topic content and continue studying without an internet connection — perfect for students with limited connectivity. MULTILINGUAL Full support for English, Persian (Dari), and Pashto, built for medical students across Afghanistan and the region. Available on iPhone, iPad, and Mac.

Screenshots

DiagnosUs4 screens
Aslami MedCore4 screens

Verdict

The call

The clearest difference is monetization model: Aslami MedCore at free against DiagnosUs's free with in-app purchases. DiagnosUs's advantage is ratings volume (1K vs 3). On price, rating, update cadence and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 4.8 for DiagnosUs against 4.7 for Aslami MedCore. That said, the two scores are not equally well evidenced: DiagnosUs has 1K ratings behind it against 3, so its average is the more settled of the two.

UpkeepUpdate frequency

Both ship on a similar rhythm, roughly fortnightly. The most recent releases landed on October 22, 2026 and October 24, 2026 respectively.

Scorecard2 real differences · 8 level
DiagnosUs versus Aslami MedCore: the parameters behind the verdict, then further details
ParameterDiagnosUsAslami MedCore
PriceFreeFree
Rating4.8 (1K ratings) — better4.7 (3 ratings)
Positive reviews79.4% of reviews—
Number of ratings1K — better3
Update frequencyFortnightlyFortnightly
AdsNoNo
In-app purchasesNoNo
MonetizationFree with in-app purchasesFree — better
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS16.015.0 — better
Further details — not scored
Size42 MB270 MB
Age rating17+4+
DeveloperCentaur LabsNawid Noori

Customer experience

DiagnosUs

All ratings1,014 ratings
Positive94.4%
Neutral1.9%
Negative3.7%
Written reviews228 reviews
Positive79.4%
Neutral10.1%
Negative10.5%

Aslami MedCore

All ratings4 ratings
Positive100.0%
Neutral0.0%
Negative0.0%

Bugs and requests

DiagnosUs

Reported bugs

4 issues
  • App crashes and freezes
  • Inaccurate or inconsistent grading of answers
  • Withdrawal and payment issues for some users
  • Compatibility problems with certain devices and OS versions

Requested features

5 requests
  • More diverse medical topics and case studies
  • Separate competitions for students vs. professionals
  • Ability to discuss and provide feedback on cases
  • Improved instructions and explanations
  • Compatibility with older devices and iOS versions

Aslami MedCore

Not enough reviews yet to summarise bugs or requests.

In-app purchases

None

DiagnosUs

No in-app purchases

None

Aslami MedCore

No in-app purchases

Questions

Is DiagnosUs free?
DiagnosUs is free to download, with no in-app purchases.
Is Aslami MedCore free?
Aslami MedCore is free to download, with no in-app purchases.
Which has better reviews, DiagnosUs or Aslami MedCore?
DiagnosUs is rated higher. DiagnosUs averages 4.8 out of 5 from 1K ratings, while Aslami MedCore averages 4.7 from 3 ratings.
Do DiagnosUs or Aslami MedCore have ads?
Neither DiagnosUs nor Aslami MedCore shows ads.
Which is updated more often, DiagnosUs or Aslami MedCore?
DiagnosUs ships an update fortnightly, and Aslami MedCore fortnightly. Most recently, DiagnosUs was updated on October 22, 2026 and Aslami MedCore on October 24, 2026.

Other comparisons